Ganguly P, Sonnichsen W J
Br J Haematol. 1976 Oct;34(2):291-301. doi: 10.1111/j.1365-2141.1976.tb00199.x.
Thrombin binds tightly to human platelets. The binding reaction is dependent on the thrombin concentration used. At a physiologically significant thrombin concentration, there are about 500 binding sites per platelet with an apparent dissociation constant of 0.02 u/ml. Autoradiography studies of platelets treated with labelled thrombin showed that the thrombin was located on the platelet surface. Separation of the subcellular fractions of platelets treated with labelled thrombin by density gradient centrifugation revealed that the membrane area contained over 80% of the radioactivity initially applied. Furthermore, isolated platelet membranes dind thrombin similar to intact platelets. These data suggest that the receptors for thrombin are located on the platelet membrane. Cytochalasin A, cytochalasin B or prostoglandin E1 did not have any effect on thrombin binding although these agents inhibited platelet aggregation. Thus, binding of thrombin is not sufficient for aggregation of platelets and other steps are involved. These agents do not affect the induction of stimulation but interfere at a later step in the trhombin-platelet interaction. On the other hand, hirudin completely inhibited binding of thrombin to platelets. It appears that the platelet receptor recognizes that part of the thrombin molecule on its surface which hirudin. Binding studies with serotonin loaded platelets showed a close correlation between thrombin binding and the release reaction.
凝血酶与人类血小板紧密结合。结合反应取决于所使用的凝血酶浓度。在具有生理意义的凝血酶浓度下,每个血小板约有500个结合位点,表观解离常数为0.02单位/毫升。对用标记凝血酶处理的血小板进行放射自显影研究表明,凝血酶位于血小板表面。通过密度梯度离心分离用标记凝血酶处理的血小板的亚细胞组分,发现膜部分含有最初施加的放射性的80%以上。此外,分离的血小板膜结合凝血酶的情况与完整血小板相似。这些数据表明,凝血酶的受体位于血小板膜上。细胞松弛素A、细胞松弛素B或前列腺素E1对凝血酶结合没有任何影响,尽管这些药物抑制血小板聚集。因此,凝血酶的结合不足以使血小板聚集,还涉及其他步骤。这些药物不影响刺激的诱导,但在凝血酶-血小板相互作用的后期步骤中起干扰作用。另一方面,水蛭素完全抑制凝血酶与血小板的结合。看来血小板受体识别凝血酶分子表面与水蛭素结合的部分。对加载5-羟色胺的血小板进行的结合研究表明,凝血酶结合与释放反应之间密切相关。